Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation-Reference-Cited by-同舟云学术

Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation

Published:2020-05 Issue:1 Volume:526 Page:273-280
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Wu Jingwei,Ma Yangchun,Zhou Hui,Zhou Liang,Du Shan,Sun Yingzhan,Li Weiya,Dong Weili,Wang Runling

Funder

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City, China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies;Kenny;Circ. Res.,2019

2. Epidemiology of diabetes;Forouhi;Medicine,2019

3. PTP1B, a potential target of type 2 diabetes mellitus;Sun;Mol. Biol.,2016

4. Protein tyrosine phosphatases: from genes, to function, to disease;Tonks;Nat. Rev. Mol. Cell Biol.,2006

5. Molecular pathways: targeting protein tyrosine phosphatases in cancer;Bollu;Clin. Canc. Res.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Discovery of Indole-2-carboxylic Acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors;Molecules;2023-12-08

2. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics;Chemical Biology & Drug Design;2023-05-25

3. What Can De Novo Protein Design Bring to the Treatment of Hematological Disorders?;Biology;2023-01-20

4. Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century;Pharmaceuticals;2022-07-14

5. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders;Bioorganic Chemistry;2022-04